Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients

Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.

Abstract

Aim: Vitamin D modulates biological processes; an influence of vitamin D levels and genetic variants was identified concerning hepatitis B virus infection. We evaluated the role of some SNPs of vitamin D pathway genes in some clinical features of hepatitis B affected patients treated with pegylated interferon.

Methods: We investigated SNPs in IL-28B, CYP27B1, CYP27A1, CYP24A1, VDBP and VDR genes, through real-time PCR.

Results: VDRApaI SNP was associated to viral load and HBsAg presence at different timings. In logistic regression analyses, VDRApaI AA genotype predicted baseline viral load >6 Log IU/ml (marker of nonresponse), and both virological and biochemical responses.

Conclusion: Pharmacogenetic data could help physicians in the prediction of patients with higher probability to achieve a good response.

Keywords: VDR genes; calcitriol; pharmacogenetics.

MeSH terms

  • Adult
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Cohort Studies
  • Female
  • Hepatitis B / blood
  • Hepatitis B / drug therapy
  • Hepatitis B / genetics
  • Hepatitis B e Antigens / blood
  • Hepatitis B e Antigens / genetics*
  • Humans
  • Interferon-alpha / pharmacology
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics*
  • Receptors, Calcitriol / blood
  • Receptors, Calcitriol / genetics*
  • Retrospective Studies
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Treatment Outcome
  • Vitamin D / blood
  • Vitamin D / genetics*

Substances

  • Antiviral Agents
  • Hepatitis B e Antigens
  • Interferon-alpha
  • Receptors, Calcitriol
  • Vitamin D